Asia Pacific Non-Invasive Prenatal Testing Market Trends, And Forecasts (20162021)
Asia Pacific Non-Invasive Prenatal Testing Market By Instruments, Method (FCMB, Cf-DNA), By Application, By End User (Hospital, Diagnostic Labs) And By Region Industry Analysis, Size, Share, Growth, Trends, And Forecasts (20162021)
(EMAILWIRE.COM, November 09, 2017 ) According to the report Asia-Pacific Non-Invasive Prenatal Testing Market, published by Market Data Forecast, the market was worth USD 290 million in 2016 and it is projected to reach USD 740 million by 2021, at a CAGR of 20.3% from 2016 to 2021.
Non-Invasive Prenatal Testing (NIPT) is a genetic test that screens for inherited diseases and birth defects. It involves a serum screening and invasive diagnostic testing that analyses the DNA, known as cell-free DNA(cf-DNA) to precisely estimate a babys risk for a variety of genetic disorders, such as Down syndrome. It consists of common testing procedures include amniocentesis, serum biomarker testing, ultrasonography including nuchal translucency ultrasound, or genetic screening.
The gender of a foetus can also be determined using NIPT. Non- Invasive Prenatal Testing is used to identify the most common chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy 13). In some cases, these tests are done to determine if the fetus will be aborted, though physicians and patients also find it useful to diagnose high-risk pregnancies early so that delivery can be scheduled in a tertiary care hospital where the baby can receive appropriate care.
Get a comprehensive overview of the Asia-Pacific Non-Invasive Prenatal Testing Market: http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/
Asia-Pacific Non-Invasive Prenatal Testing Market: Drivers & Restraints
Introduction of newer and more advanced NIPT products, growing preference for non-invasive techniques over invasive methods, increasing awareness programs, increasing risk of chromosomal abnormalities in babies with growing maternal age and favourable reimbursement for NIPT, increasing maternal age and untapped emerging markets are the major factors driving the growth of the market. However, projected NIPT-related price erosion and lack of professionals are restraining the growth of this market.
Get accurate market forecast and analysis on the Asia-Pacific Non-Invasive Prenatal Testing Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/request-sample
Asia-Pacific Non-Invasive Prenatal Testing Market: Segmentation
By Instruments
o PCR
o Ultrasound
o NGS
o Microarray
By Method
o FCMB
o Cell-Free DNA (cf-DNA)
By Application
o Trisomy
o Microdeletion
o Genetics
o Rh factor
By End User
o Hospital
o Diagnostic Labs
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/customize-report
Asia-Pacific Non-Invasive Prenatal Testing Market: Overview
A gradual shift in the upper ceiling for the global average of maternal age and the rise in the incidence of down syndrome in new born have boosted demand to a significant level. In addition, expansion of coverage by payers to low & average-risk pregnancies over the forecast period in order to save on amniocentesis and the treatment of down Syndrome is anticipated to enhance the penetration of NIPT products, consequently influencing revenue generation. On the other hand, companies playing a pivotal role are focusing on the development of novel technology for determining chromosomal aberrations in the cf DNA (cell free DNA) sample.
Asia-Pacific Non-Invasive Prenatal Testing Market: Region-wise Outlook
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as growing demographics with rising awareness and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. In fact, Asia-Pacific is the fast developing NIPT market which is reflected in its CAGR of more than 20%, which is the highest globally. Availability of humongous untapped markets and huge population base are driving the upsurge in growth.
Key Questions Answered
What is the current and future Non-Invasive Prenatal Testing Market in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Non-Invasive Prenatal Testing market in the Asia-Pacific?
What are the key, high growth markets that Non-Invasive Prenatal Testing equipment should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Non-Invasive Prenatal Testing currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of the Non-Invasive Prenatal Testing?
What are the challenges and barriers that have hindered widespread adoption of Non-Invasive Prenatal Testing?
Asia-Pacific Non-Invasive Prenatal Testing Market: Key Players
The Asia-Pacific Non-Invasive Prenatal Testing market is very much disjointed in nature with the existence of international and local players. The significant players in the Asia-Pacific Non-Invasive Prenatal Testing market are GE Healthcare, Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Agilent Technologies, Inc., and Beijing Genomics Institute.
Reasons to buy Asia-Pacific Non-Invasive Prenatal Testing Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Non-Invasive Prenatal Testing (NIPT) is a genetic test that screens for inherited diseases and birth defects. It involves a serum screening and invasive diagnostic testing that analyses the DNA, known as cell-free DNA(cf-DNA) to precisely estimate a babys risk for a variety of genetic disorders, such as Down syndrome. It consists of common testing procedures include amniocentesis, serum biomarker testing, ultrasonography including nuchal translucency ultrasound, or genetic screening.
The gender of a foetus can also be determined using NIPT. Non- Invasive Prenatal Testing is used to identify the most common chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy 13). In some cases, these tests are done to determine if the fetus will be aborted, though physicians and patients also find it useful to diagnose high-risk pregnancies early so that delivery can be scheduled in a tertiary care hospital where the baby can receive appropriate care.
Get a comprehensive overview of the Asia-Pacific Non-Invasive Prenatal Testing Market: http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/
Asia-Pacific Non-Invasive Prenatal Testing Market: Drivers & Restraints
Introduction of newer and more advanced NIPT products, growing preference for non-invasive techniques over invasive methods, increasing awareness programs, increasing risk of chromosomal abnormalities in babies with growing maternal age and favourable reimbursement for NIPT, increasing maternal age and untapped emerging markets are the major factors driving the growth of the market. However, projected NIPT-related price erosion and lack of professionals are restraining the growth of this market.
Get accurate market forecast and analysis on the Asia-Pacific Non-Invasive Prenatal Testing Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/request-sample
Asia-Pacific Non-Invasive Prenatal Testing Market: Segmentation
By Instruments
o PCR
o Ultrasound
o NGS
o Microarray
By Method
o FCMB
o Cell-Free DNA (cf-DNA)
By Application
o Trisomy
o Microdeletion
o Genetics
o Rh factor
By End User
o Hospital
o Diagnostic Labs
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/asia-pacific-non-Invasive-prenatal-testing-market-2821/customize-report
Asia-Pacific Non-Invasive Prenatal Testing Market: Overview
A gradual shift in the upper ceiling for the global average of maternal age and the rise in the incidence of down syndrome in new born have boosted demand to a significant level. In addition, expansion of coverage by payers to low & average-risk pregnancies over the forecast period in order to save on amniocentesis and the treatment of down Syndrome is anticipated to enhance the penetration of NIPT products, consequently influencing revenue generation. On the other hand, companies playing a pivotal role are focusing on the development of novel technology for determining chromosomal aberrations in the cf DNA (cell free DNA) sample.
Asia-Pacific Non-Invasive Prenatal Testing Market: Region-wise Outlook
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as growing demographics with rising awareness and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. In fact, Asia-Pacific is the fast developing NIPT market which is reflected in its CAGR of more than 20%, which is the highest globally. Availability of humongous untapped markets and huge population base are driving the upsurge in growth.
Key Questions Answered
What is the current and future Non-Invasive Prenatal Testing Market in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Non-Invasive Prenatal Testing market in the Asia-Pacific?
What are the key, high growth markets that Non-Invasive Prenatal Testing equipment should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Non-Invasive Prenatal Testing currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of the Non-Invasive Prenatal Testing?
What are the challenges and barriers that have hindered widespread adoption of Non-Invasive Prenatal Testing?
Asia-Pacific Non-Invasive Prenatal Testing Market: Key Players
The Asia-Pacific Non-Invasive Prenatal Testing market is very much disjointed in nature with the existence of international and local players. The significant players in the Asia-Pacific Non-Invasive Prenatal Testing market are GE Healthcare, Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Agilent Technologies, Inc., and Beijing Genomics Institute.
Reasons to buy Asia-Pacific Non-Invasive Prenatal Testing Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results